Navigation Links
Executive Order Will In No Way Prevent Federal Funding of Elective Abortion
Date:3/21/2010

WASHINGTON, March 21 /PRNewswire-USNewswire/ -- Family Research Council President Tony Perkins released the following statement in response to reports that President Obama may issue an executive order regarding government funding of elective abortions in the Senate health care bill (H.R. 3590):

"Those few pro-life Democrats that would place the fate of the unborn in the hands of the President, will be placing their own political fate in those same hands secured only by a promise that runs counter to everything he has said and done.

"By offering an executive order as a so-called solution, President Obama is finally admitting there is a problem with a bill that would force taxpayers to pay for elective abortions for the first time in over three decades. However, there is no way that an executive order will protect the unborn or prevent the greatest expansion of elective abortion since Roe v. Wade.

"Pro-life lawmakers would be making a serious mistake to trust those who have repeatedly attempted to mislead the American people into believing that abortion is not in the bill.

President Obama and the Democratic leadership know that such a plan, due to legal precedent, would be worth little in the long run. Court rulings in cases such as Commerce of U.S. v Reich and Hamdan v. Rumsfeld make it very clear that such an executive order likely wouldn't survive.

"Regardless of any executive order, the reconciliation bill will make matters worse by increasing funding for community health centers, which will bypass any abortion funding restrictions in appropriations bills because it is directly appropriated.

"The President could also lift such an executive order at any time with a stroke of a pen. During the campaign, President Obama promised he would treat abortion as a basic health care mandate for both taxpayers and private health insurers to subsidize. He told Planned Parenthood that 'reproductive care' would be at the 'center' of his health care plan.

"And after only three days in office, he lifted the Mexico City Policy which prohibited taxpayer funds from going to foreign non-governmental organizations that promote and perform abortions.

"Since massive abortion funding remains in these bills and an executive order would provide no protections, FRC Action still plans to score votes on both the Senate bill and on the reconciliation bill in our annual scorecard."

Download summary of abortion funding in the bill http://downloads.frcaction.org/EF/EF10C07.pdf

A chart comparing the Stupak-Pitts amendment language in the original House passed bill vs. abortion language in H.R. 3590. http://downloads.frcaction.org/EF/EF10C08.pdf).

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO )

SOURCE Family Research Council

Back to top

RELATED LINKS
http://www.frc.org

'/>"/>

SOURCE Family Research Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Foundation Radiology Group Adds Barbara Beaudin, Chief Financial Officer, to Executive Management Staff
2. Elizabeth Glaser Pediatric AIDS Foundation President and CEO Charles Lyons Welcomes the Appointment of Anthony Lake as New Executive Director of UNICEF
3. Bausch + Lomb Names Fred Hassan as Chairman, Brent Saunders as Chief Executive Officer
4. Cell Science Systems Recruits Seasoned Executive to Head New Lifestyle Medicine & Nutritional Solution for Health Care Professionals
5. Navvis & Company Acquires Physician Executive Management Center
6. NightHawk Radiology Services Expands Its Medical Executive Team
7. Tom Rios Named Executive Director at Splendido
8. LocumTenens.com Names Lisa Kaeck Executive Vice President
9. LocumTenens.com Announces Key Executive Promotions
10. Advans Survey Reveals that 75 Percent of Executives Prefer Domestic Outsourcing vs. Offshore
11. BioMed Realty Trust Promotes Matthew G. McDevitt to Executive Vice President, Real Estate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... VisualSP has ... sustainably. Until recently, the only option for on-premises installation of its Help System for ... required to install the system into the entire tenant. , The company recently ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies announced ... address the resolution to globally reduce the harmful use of alcohol set forth ... and TTB approved ingredients that when infused into alcohol, renders the alcohol liver ...
(Date:3/28/2017)... ... 29, 2017 , ... The Thyroid Secret is a specialized ... The program was recently launched on March 1, and Dr. Wentz discussed varied ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the science and clinical practice of radiosurgery, announced today the publication of ... observational registry established to standardize data collection from patients treated with stereotactic ...
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. ... , Medical doctors and PhD scientists will speak to the press on behalf of ... support of an independent vaccine safety commission. , WHERE: , Zenger Room, National ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... /PRNewswire/ - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a specialty ... year ended December 31, 2016 after market close ... being released later than the previous fiscal year,s ... operations and balances of Apicore from the acquisition ... filing date meets TSX Venture Exchange listed company ...
(Date:3/28/2017)... 28, 2017 The global emerging cancer diagnostics ... 13.45% from 2016 to 2023 and reach a figure ... Cancer is a chronic disease and is affecting a ... diagnostics market. This report is focused on emerging cancer ... growth is propelled due to factors such as: increasing ...
(Date:3/28/2017)... SPRING, Md. , March 28, 2017 /PRNewswire-USNewswire/ ... approved Dupixent (dupilumab) injection to treat adults with ... patients whose eczema is not controlled adequately by ... are not advisable. Dupixent can be used with ... of Dupixent demonstrates our commitment to approving new ...
Breaking Medicine Technology: